Cyclophosphamide 1GM, 2GM and 500MG vial INJ.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0040
- Awardee
-
Baxter Healthcare Corporation UEI RSKLEFCZ6127
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Cyclophosphamide inj (VA-20-00039506) Pre-Solicitation · 36E79720R0031 · Posted Apr 14, 2020
- 6505--Cyclophosphamide inj (VA-20-00039506) Award Notice · Posted Jun 17, 2020
- 6505--Cyclophosphamide inj (VA-20-00039506) Solicitation · Posted Apr 23, 2020
- Last date to order 100% complete
- IDV ceiling
- $30,336,036.80
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Baxter Healthcare Corporation on October 15, 2020, with a potential value of $30,336,036.80. The contract provides for the supply of cyclophosphamide vial injections in 1gm, 2gm, and 500mg sizes to the VA, DOD, BOP and IHS. The pre-solicitation notice indicated annual estimated requirements totaling over 12,000 vials across the three sizes, ranging from over 4,000 to 5,486 vials per size. The contract period is one base year plus four one-year option periods, with an end date for ordering on October 14, 2022.
The originating pre-solicitation from April 14, 2020 sought proposals for an unrestricted contract to provide an uninterrupted supply of cyclophosphamide vial injections. The solicitation was issued on May 4, 2020 via SAM.gov with a response due date of May 18, 2020. The contract was to be awarded to the responsible offeror able to supply the exact product names and NDC numbers as identified in their proposal. No set-aside was designated. The purpose of the contract is to distribute the injections to the respective Pharmaceutical Prime Vendor Programs of the VA and DOD to support patient care.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79720D0040?
36E79720D0040 was awarded to Baxter Healthcare Corporation by National Acquisition Center (Headquarters) on October 15, 2020.
How much is contract 36E79720D0040 worth?
36E79720D0040's own ceiling is $30,336,037.
Who can order from contract 36E79720D0040?
36E79720D0040 is a single award indefinite delivery contract.
Was contract 36E79720D0040 competed?
The extent of competition for 36E79720D0040 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV